{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T19:12:16Z","timestamp":1762888336541,"version":"3.45.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31771971","32001013"],"award-info":[{"award-number":["31771971","32001013"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.eclinm.2021.101180","type":"journal-article","created":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T11:47:14Z","timestamp":1635594434000},"page":"101180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Evaluation of dithiothreitol-oxidizing capacity (DOC) as a serum biomarker for chronic hepatitis B in patients exhibiting normal alanine aminotransferase levels: a pilot study towards better monitoring of disease"],"prefix":"10.1016","volume":"42","author":[{"given":"Lumin","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yafei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tengfei","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias S J","family":"Arn\u00e9r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9366-9819","authenticated-orcid":false,"given":"Jinsong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2021.101180_bib0001","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/liv.13682","article-title":"Liver diseases: A major, neglected global public health problem requiring urgent actions and large-scale screening","volume":"38","author":"Marcellin","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.eclinm.2021.101180_bib0002","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cca.2013.03.030","article-title":"Upper limit of normal for alanine aminotransferase: quo vadis?","volume":"422","author":"Pacifico","year":"2013","journal-title":"Clin Chim Acta"},{"issue":"6","key":"10.1016\/j.eclinm.2021.101180_bib0003","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1053\/jhep.2003.50229","article-title":"Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values","volume":"37","author":"Mofrad","year":"2003","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.eclinm.2021.101180_bib0004","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jhep.2007.07.022","article-title":"The clinical significance of persistently normal ALT in chronic hepatitis B infection","volume":"47","author":"Lai","year":"2007","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.eclinm.2021.101180_bib0005","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2036.2008.03896.x","article-title":"Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels","volume":"29","author":"Wong","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.eclinm.2021.101180_bib0006","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2893.2009.01150.x","article-title":"Implication of normal liver enzymes in liver disease","volume":"16","author":"Calvaruso","year":"2009","journal-title":"J Viral Hepat"},{"issue":"1","key":"10.1016\/j.eclinm.2021.101180_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-137-1-200207020-00006","article-title":"Updated definitions of healthy ranges for serum alanine aminotransferase levels","volume":"137","author":"Prati","year":"2002","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.eclinm.2021.101180_bib0008","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-138-2-200301210-00021","article-title":"Healthy ranges for alanine aminotransferase levels","volume":"138","author":"De Rosa","year":"2003","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.eclinm.2021.101180_bib0009","doi-asserted-by":"crossref","first-page":"49","DOI":"10.7326\/0003-4819-137-1-200207020-00012","article-title":"Alanine aminotransferase levels: what's normal?","volume":"137","author":"Kaplan","year":"2002","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.eclinm.2021.101180_bib0010","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/apt.12590","article-title":"Systematic review with meta-analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase <\/= 40 IU\/L and significant hepatic fibrosis","volume":"39","author":"Chao","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.eclinm.2021.101180_bib0011","doi-asserted-by":"crossref","first-page":"18035","DOI":"10.1038\/nrdp.2018.35","article-title":"Hepatitis B virus infection","volume":"4","author":"Yuen","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"10.1016\/j.eclinm.2021.101180_bib0012","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.eclinm.2021.101180_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol Int"},{"issue":"8","key":"10.1016\/j.eclinm.2021.101180_bib0014","first-page":"568","article-title":"Expert consensus on diagnosis and treatment of end-stage liver disease complicated with infections","volume":"26","year":"2018","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"6","key":"10.1016\/j.eclinm.2021.101180_bib0015","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/jmv.22048","article-title":"High prevalence of significant liver fibrosis and cirrhosis in chronic hepatitis B patients with normal ALT in central Europe","volume":"83","author":"Gobel","year":"2011","journal-title":"J Med Virol"},{"key":"10.1016\/j.eclinm.2021.101180_bib0016","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/liv.14359","article-title":"Approach to the patient with chronic hepatitis B and decompensated cirrhosis","volume":"40","author":"Shiffman","year":"2020","journal-title":"Liver Int"},{"issue":"22","key":"10.1016\/j.eclinm.2021.101180_bib0017","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.3748\/wjg.v19.i22.3481","article-title":"Efficacy of combined therapy in patients with hepatitis B virus-related decompensated cirrhosis","volume":"19","author":"Lv","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.eclinm.2021.101180_bib0018","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.bbagen.2014.02.028","article-title":"Serum thioredoxin reductase levels increase in response to chemically induced acute liver injury","volume":"1840","author":"Sun","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.eclinm.2021.101180_bib0019","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.freeradbiomed.2016.08.028","article-title":"Serum thioredoxin reductase is highly increased in mice with hepatocellular carcinoma and its activity is restrained by several mechanisms","volume":"99","author":"Zhang","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.eclinm.2021.101180_bib0020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.freeradbiomed.2014.01.020","article-title":"Disulfide bond generation in mammalian blood serum: detection and purification of quiescin-sulfhydryl oxidase","volume":"69","author":"Israel","year":"2014","journal-title":"Free Radic Biol Med"},{"issue":"14","key":"10.1016\/j.eclinm.2021.101180_bib0021","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1001\/jama.2018.1536","article-title":"The Proposal to Lower P Value Thresholds to. 005","volume":"319","author":"Ioannidis","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.eclinm.2021.101180_bib0022","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12872-017-0485-6","article-title":"Association of serum transaminases with short- and long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"17","author":"Gao","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"10.1016\/j.eclinm.2021.101180_bib0023","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/MCA.0b013e32834e4ef1","article-title":"Pattern of liver enzyme elevations in acute ST-elevation myocardial infarction","volume":"23","author":"Lofthus","year":"2012","journal-title":"Coron Artery Dis"},{"issue":"6","key":"10.1016\/j.eclinm.2021.101180_bib0024","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1053\/jhep.2002.33638","article-title":"Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B","volume":"35","author":"Hsu","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.eclinm.2021.101180_bib0025","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1743-422X-2-82","article-title":"Hepatitis B virus: inactive carriers","volume":"2","author":"Sharma","year":"2005","journal-title":"Virol J"},{"issue":"2","key":"10.1016\/j.eclinm.2021.101180_bib0026","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1042\/BJ20130360","article-title":"Proteolytic processing of QSOX1A ensures efficient secretion of a potent disulfide catalyst","volume":"454","author":"Rudolf","year":"2013","journal-title":"Biochem J"},{"issue":"8","key":"10.1016\/j.eclinm.2021.101180_bib0027","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/glycob\/cwy044","article-title":"Quiescin sulfhydryl oxidase 1 (QSOX1) glycosite mutation perturbs secretion but not Golgi localization","volume":"28","author":"Horowitz","year":"2018","journal-title":"Glycobiology"},{"issue":"37","key":"10.1016\/j.eclinm.2021.101180_bib0028","doi-asserted-by":"crossref","first-page":"62011","DOI":"10.18632\/oncotarget.18782","article-title":"Identification of CD14 as a potential biomarker of hepatocellular carcinoma using iTRAQ quantitative proteomics","volume":"8","author":"Guo","year":"2017","journal-title":"Oncotarget"},{"issue":"45","key":"10.1016\/j.eclinm.2021.101180_bib0029","doi-asserted-by":"crossref","first-page":"31759","DOI":"10.1074\/jbc.274.45.31759","article-title":"Homology between egg white sulfhydryl oxidase and quiescin Q6 defines a new class of flavin-linked sulfhydryl oxidases","volume":"274","author":"Hoober","year":"1999","journal-title":"J Biol Chem"},{"issue":"6141","key":"10.1016\/j.eclinm.2021.101180_bib0030","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.1238279","article-title":"A secreted disulfide catalyst controls extracellular matrix composition and function","volume":"341","author":"Ilani","year":"2013","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.eclinm.2021.101180_bib0031","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nrm3607","article-title":"Cell adhesion: Extracellular bonds","volume":"14","author":"Baumann","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.eclinm.2021.101180_bib0032","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1089\/ars.2013.5572","article-title":"The emerging role of QSOX1 in cancer","volume":"21","author":"Lake","year":"2014","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"10.1016\/j.eclinm.2021.101180_bib0033","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cld.2008.07.008","article-title":"Cellular sources of extracellular matrix in hepatic fibrosis","volume":"12","author":"Wells","year":"2008","journal-title":"Clin Liver Dis"},{"issue":"1","key":"10.1016\/j.eclinm.2021.101180_bib0034","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/apt.15773","article-title":"Review article: the signalling and functional role of the extracellular matrix in the development of liver fibrosis","volume":"52","author":"Villesen","year":"2020","journal-title":"Aliment Pharmacol Ther"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537021004600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537021004600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T19:08:11Z","timestamp":1762888091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537021004600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":34,"alternative-id":["S2589537021004600"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2021.101180","relation":{},"ISSN":["2589-5370"],"issn-type":[{"type":"print","value":"2589-5370"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of dithiothreitol-oxidizing capacity (DOC) as a serum biomarker for chronic hepatitis B in patients exhibiting normal alanine aminotransferase levels: a pilot study towards better monitoring of disease","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2021.101180","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101180"}}